Preliminary expression profile of cytokines in brain tissue of BALB/c mice with Angiostrongylus cantonensis infection

Parasites and Vectors

Volumn 8, Issue 1, 2015, Pages

  Yu, Liping ^a,b   Wu, Xiaoying ^c   Wei, Jie ^b,c   Liao, Qi ^d   Xu, Lian ^b,c   Luo, Siqi ^b,c   Zeng, Xin ^b,c   Zhao, Yi ^e   Lv, Zhiyue ^b,c   Wu, Zhongdao ^b,c  

^a CHINA THREE GORGES UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d NINGBO UNIVERSITY   (China)

^e INSTITUTE OF COMPUTING TECHNOLOGY   (China)

Author keywords

Angiostrongylus cantonensis; Chemokine; Cytokine; Eosinophil; Mouse model

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; CCL1 CHEMOKINE; CYTOKINE; EOTAXIN; EOTAXIN 2; INTERLEUKIN 10; INTERLEUKIN 11; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 16; INTERLEUKIN 18; INTERLEUKIN 19; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 23P19; INTERLEUKIN 25; INTERLEUKIN 27; INTERLEUKIN 3; INTERLEUKIN 33; INTERLEUKIN 34; INTERLEUKIN 4; INTERLEUKIN 5; LONG UNTRANSLATED RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 5; RANTES; UNINDEXED DRUG;

ANGIOSTRONGYLIASIS; ANGIOSTRONGYLUS CANTONENSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BIOINFORMATICS; BRAIN INJURY; BRAIN TISSUE; CCL1 GENE; CCL11 GENE; CCL12 GENE; CCL17 GENE; CCL19 GENE; CCL2 GENE; CCL21A GENE; CCL21B GENE; CCL22 GENE; CCL24 GENE; CCL25 GENE; CCL27A GENE; CCL27B GENE; CCL3 GENE; CCL4 GENE; CCL5 GENE; CCL6 GENE; CCL7 GENE; CCL8 GENE; CCL9 GENE; CONTROLLED STUDY; DEEP SEQUENCING; EOSINOPHIL; GENE; GENE EXPRESSION; IL10; IL11 GENE; IL13 GENE; IL15 GENE; IL16 GENE; IL18 GENE; IL19 GENE; IL1A GENE; IL1B GENE; IL1F5 GENE; IL22 GENE; IL23A GENE; IL25 GENE; IL27 GENE; IL3 GENE; IL33 GENE; IL34 GENE; IL4 GENE; IL5 GENE; IL6 GENE; ILF2 GENE; ILF3 GENE; ILLUMINA SEQUENCING; INFLAMMATION; MOLECULAR LIBRARY; MOUSE; NEUROPATHIC PAIN; NONHUMAN; PREDICTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REFSEQ GENES EXPRESSION ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SEQUENCE ANALYSIS; TH2 CELL; TRANSCRIPTOMICS; UPREGULATION; ANIMAL; BRAIN; DISEASE MODEL; GENETICS; HUMAN; IMMUNOLOGY; MALE; METABOLISM; PARASITOLOGY; PHYSIOLOGY; STRONGYLE INFECTION;

ANGIOSTRONGYLUS CANTONENSIS; MUS;

ANGIOSTRONGYLUS CANTONENSIS; ANIMALS; BRAIN; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICE; MICE, INBRED BALB C; STRONGYLIDA INFECTIONS;

EID: 84934944864     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/s13071-015-0939-6     Document Type: Article

References (54)

1. Moreira VL, Giese EG, Melo FT, Simoes RO, Thiengo SC, Maldonado Jr A, et al. Endemic angiostrongyliasis in the Brazilian Amazon: natural parasitism of Angiostrongylus cantonensis in Rattus rattus and R. norvegicus, and sympatric giant African land snails, Achatina fulica. Acta Trop. 2013;125(1):90-7.
2. Eamsobhana P. Angiostrongyliasis in Thailand: epidemiology and laboratory investigations. Hawaii J Med Public Health. 2013;72(6 Suppl 2):28-32.
3. Lunn JA, Lee R, Smaller J, MacKay BM, King T, Hunt GB, et al. Twenty two cases of canine neural angiostronglyosis in eastern Australia (2002-2005) and a review of the literature. Parasit Vectors. 2012;5:70.
4. Deng ZH, Lv S, Lin JY, Lin RX, Pei FQ. An outbreak of angiostrongyliasis in Guanging, People's Republic of China: migrants vulnerable to an emerging disease. Southeast Asian J Trop Med Public Health. 2011;42(5):1047-53.
5. Evans-Gilbert T, Lindo JF, Henry S, Brown P, Christie CD. Severe eosinophilic meningitis owing to Angiostrongylus cantonensis in young Jamaican children: case report and literature review. Paediatr Int Child Health. 2014;34(2):148-52.
6. Padilla-Docal B, Iglesias-Gonzalez I, Bu-Coifiu-Fanego R, Socarras-Hernandez CA, Dorta-Contreras AJ. Intrathecal activation as a typical immune response within the central nervous system in angiostrongyliasis. Am J Trop Med Hyg. 2013;88(2):230-5.
7. Slom T, Johnson S. Eosinophilic Meningitis. Curr Infect Dis Rep. 2003;5(4):322-8.
8. Wiwanitkit S, Wiwanitkit V. Eosinophilic meningitis due to Angiostrongylus cantonensis with confirmed finding of intrathecal parasite. Arq Neuropsiquiatr. 2014;72(3):261.
9. Morassutti AL, Thiengo SC, Fernandez M, Sawanyawisuth K, Graeff-Teixeira C. Eosinophilic meningitis caused by Angiostrongylus cantonensis: an emergent disease in Brazil. Mem Inst Oswaldo Cruz. 2014;109(4):399-407.
10. Liu LH, He HJ, Lv ZY, Wei J, Zeng X, Liang JY, et al. The mRNA level of the galectin-10 of Angiostrongylus cantonensis induced by reactive oxygen stress. Parasitol Res. 2013;112(3):933-43.
11. Intapan PM, Kittimongkolma S, Niwattayakul K, Sawanyawisuth K, Maleewong W. Cerebrospinal fluid cytokine responses in human eosinophilic meningitis associated with angiostrongyliasis. J Neurol Sci. 2008;267(1-2):17-21.
12. Lv S, Zhang Y, Chen SR, Wang LB, Fang W, Chen F, et al. Human angiostrongyliasis outbreak in Dali China. PLoS Negl Trop Dis. 2009;3(9), e520.
13. Oehler E, Ghawche F, Delattre A, Berberian A, Levy M, Valour F. Angiostrongylus cantonensis eosinophilic meningitis: a clinical study of 42 consecutive cases in French Polynesia. Parasitol Int. 2014;63(3):544-9.
14. Iwata T, Fujii T, Morii K, Saito M, Sugiyama J, Nishio H, et al. Cytokine profile in cervical mucosa of Japanese patients with cervical intraepithelial neoplasia. Int J Clin Oncol. 2014;20(1):126-33.
15. Teixeira MM, Wells TN, Lukacs NW, Proudfoot AE, Kunkel SL, Williams TJ, et al. Chemokine-induced eosinophil recruitment: Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. J Clin Invest. 1997;100(7):1657-66.
16. Lukacs NW, Standiford TJ, Chensue SW, Kunkel RG, Strieter RM, Kunkel SL. C-C chemokine-induced eosinophil chemotaxis during allergic airway inflammation. J Leukoc Biol. 1996;60(5):573-8.
17. Lukacs NW, Prosser DM, Wiekowski M, Lira SA, Cook DN. Requirement for the chemokine receptor CCR6 in allergic pulmonary inflammation. J Exp Med. 2001;194(4):551-5.
18. Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol. 2001;2(2):108-15.
19. Ying S, Robinson DS, Meng Q, Barata LT, McEuen AR, Buckley MG, et al. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES). J Immunol. 1999;163(7):3976-84.
20. Chang EE, Chung LY, Yen CM. Kinetics of change in the eotaxin concentration in serum and cerebrospinal fluid of mice infected with Angiostrongylus cantonensis. Parasitol Res. 2004;92(2):137-41.
21. Li S, Yang F, Ji P, Zeng X, Wu X, Wei J, et al. Eosinophil chemotactic chemokine profilings of the brain from permissive and non-permissive hosts infected with Angiostrongylus cantonenis. Parasitol Res. 2014;113(2):517-25.
22. Feng Y, Zeng X, Li WH, Wang WC, Ou-Yang LS, Sun X, et al. Animal model of human disease with optic neuritis: neuropapillitis in a rat model infected with Angiostrongylus cantonensis. Parasitol Res. 2014;113(11):4005-13.
23. Yu L, Liao Q, Zeng X, Lv Z, Zheng H, Zhao Y, et al. MicroRNA expressions associated with eosinophilic meningitis caused by Angiostrongylus cantonensis infection in a mouse model. Eur J Clin Microbiol Infect Dis. 2014;33(8):1457-65.
24. Bauer BK, Isom SC, Spate LD, Whitworth KM, Spollen WG, Blake SM, et al. Transcriptional profiling by deep sequencing identifies differences in mRNA transcript abundance in in vivo-derived versus in vitro-cultured porcine blastocyst stage embryos. Biol Reprod. 2010;83(5):791-8.
25. Zhao Y, Luo H, Chen X, Xiao Y, Chen R. Computational methods to predict long noncoding RNA functions based on co-expression network. Methods Mol Biol. 2014;1182:209-18.
26. Liao Q, Liu C, Yuan X, Kang S, Miao R, Xiao H, et al. Large-scale prediction of long non-coding RNA functions in a coding-non-coding gene co-expression network. Nucleic Acids Res. 2011;39(9):3864-78.
27. OuYang L, Wei J, Wu Z, Zeng X, Li Y, Jia Y, et al. Differences of larval development and pathological changes in permissive and nonpermissive rodent hosts for Angiostrongylus cantonensis infection. Parasitol Res. 2012;111(4):1547-57.
28. Van Steenwinckel J, Auvynet C, Sapienza A, Reaux-Le Goazigo A, Combadiere C, Melik PS. Stromal cell-derived CCL2 drives neuropathic pain states through myeloid cell infiltration in injured nerve. Brain Behav Immun. 2015;45:198-210.
29. Guo YQ, Zheng LN, Wei JF, Hou XL, Yu SZ, Zhang WW, et al. Expression of CCL2 and CCR2 in the hippocampus and the interventional roles of propofol in rat cerebral ischemia/reperfusion. Exp Ther Med. 2014;8(2):657-61.
30. Yao Y, Tsirka SE. Monocyte chemoattractant protein-1 and the blood-brain barrier. Cell Mol Life Sci. 2014;71(4):683-97.
31. Peterson KE, Errett JS, Wei T, Dimcheff DE, Ransohoff R, Kuziel WA, et al. MCP-1 and CCR2 contribute to non-lymphocyte-mediated brain disease induced by Fr98 polytropic retrovirus infection in mice: role for astrocytes in retroviral neuropathogenesis. J Virol. 2004;78(12):6449-58.
32. Tanaka T, Minami M, Nakagawa T, Satoh M. Enhanced production of monocyte chemoattractant protein-1 in the dorsal root ganglia in a rat model of neuropathic pain: possible involvement in the development of neuropathic pain. Neurosci Res. 2004;48(4):463-9.
33. Graber DJ, Costine BA, Hickey WF. Early inflammatory mediator gene expression in two models of traumatic brain injury: ex vivo cortical slice in mice and in vivo cortical impact in piglets. J Neuroinflammation. 2015;12(1):76.
34. Hammond MD, Taylor RA, Mullen MT, Ai Y, Aguila HL, Mack M, et al. CCR2+ Ly6C (hi) inflammatory monocyte recruitment exacerbates acute disability following intracerebral hemorrhage. J Neurosci. 2014;34(11):3901-9.
35. Bose S, Cho J. Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases. Arch Pharm Res. 2013;36(9):1039-50.
36. Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, Mutoh T, et al. LPA receptors: subtypes and biological actions. Annu Rev Pharmacol Toxicol. 2010;50:157-86.
37. Islam SA, Chang DS, Colvin RA, Byrne MH, McCully ML, Moser B, et al. Mouse CCL8, a CCR8 agonist, promotes atopic dermatitis by recruiting IL-5+ T (H)2 cells. Nat Immunol. 2011;12(2):167-77.
38. Lee YG, Jeong JJ, Nyenhuis S, Berdyshev E, Chung S, Ranjan R, et al. Recruited alveolar macrophages, in response to airway epithelial-derived MCP-1/CCL2, regulate airway inflammation and remodeling in allergic asthma. Am J Respir Cell Mol Biol. 2014;52(6):772-84.
39. Suzuki Y, Asano K, Niimi K, Miyata J, Shiraishi Y, Fukunaga K, et al. TP receptor-mediated release of eosinophil chemotactic activity from human bronchial smooth muscle cells. Eur J Pharmacol. 2008;600(1-3):133-9.
40. de Nadai P, Chenivesse C, Gilet J, Porte H, Vorng H, Chang Y, et al. CCR5 usage by CCL5 induces a selective leukocyte recruitment in human skin xenografts in vivo. J Invest Dermatol. 2006;126(9):2057-64.
41. Meyer-Hoffert U, Lezcano-Meza D, Bartels J, Montes-Vizuet AR, Schroder JM, Teran LM. Th2- and to a lesser extent Th1-type cytokines upregulate the production of both CXC (IL-8 and gro-alpha) and CC (RANTES, eotaxin, eotaxin-2, MCP-3 and MCP-4) chemokines in human airway epithelial cells. Int Arch Allergy Immunol. 2003;131(4):264-71.
42. Feng Y, Zeng X, Li WH, Wang WC, Chen W, Ou-Yang LS, et al. The pathogenesis of optic neuritis caused by Angiostrongylus cantonensis in BALB/c mice. Parasit Vectors. 2014;7:339.
43. Tsai HC, Lee BY, Yen CM, Wann SR, Lee SS, Chen YS. Dexamethasone inhibits brain apoptosis in mice with eosinophilic meningitis caused by Angiostrongylus cantonensis infection. Parasit Vectors. 2015;8(1):200.
44. Garcia G, Taille C, Laveneziana P, Bourdin A, Chanez P, Humbert M. Anti-interleukin-5 therapy in severe asthma. Eur Respir Rev. 2013;22(129):251-7.
45. Fontes JA, Rose NR, Cihakova D. The varying faces of IL-6: From cardiac protection to cardiac failure. Cytokine. 2015;74(1):62-8.
46. Kunz S, Wolk K, Witte E, Witte K, Doecke WD, Volk HD, et al. Interleukin (IL)-19, IL-20 and IL-24 are produced by and act on keratinocytes and are distinct from classical ILs. Exp Dermatol. 2006;15(12):991-1004.
47. Azuma YT, Matsuo Y, Kuwamura M, Yancopoulos GD, Valenzuela DM, Murphy AJ, et al. Interleukin-19 protects mice from innate-mediated colonic inflammation. Inflamm Bowel Dis. 2010;16(6):1017-28.
48. Hsu YH, Li HH, Sung JM, Chen WT, Hou YC, Chang MS. Interleukin-19 mediates tissue damage in murine ischemic acute kidney injury. PLoS One. 2013;8(2), e56028.
49. Liao YC, Liang WG, Chen FW, Hsu JH, Yang JJ, Chang MS. IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha. J Immunol. 2002;169(8):4288-97.
50. Stenberg L, Kanje M, Dolezal K, Dahlin LB. Expression of activating transcription factor 3 (ATF 3) and caspase 3 in Schwann cells and axonal outgrowth after sciatic nerve repair in diabetic BB rats. Neurosci Lett. 2012;515(1):34-8.
51. Cai B, Song XQ, Cai JP, Zhang S. HOTAIR: acancer-related long non-coding RNA. Neoplasma. 2014;61(4):379-91.
52. Leung A, Trac C, Jin W, Lanting L, Akbany A, Saetrom P, et al. Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells. Circ Res. 2013;113(3):266-78.
53. Deng K, Guo X, Wang H, Xia J. The lncRNA-MYC regulatory network in cancer. Tumour Biol. 2014;35(10):9497-503.
54. Tran VG, Court F, Duputie A, Antoine E, Aptel N, Milligan L, et al. H19 antisense RNA can up-regulate Igf2 transcription by activation of a novel promoter in mouse myoblasts. PLoS One. 2012;7(5), e37923.